Related Experiment Videos
Peritonitis with CDC group IVc-2 bacteria in a patient on continuous ambulatory peritoneal dialysis
J Zapardiel1, G Blum, C Caramelo
1Servicio de Microbiología Clínica, Fundación Jiménez Diaz, Madrid, Spain.
Abstract:
A case of CDC group IVc-2 peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD) is described. To the authors' knowledge, this is the first case reported of CAPD peritonitis in which a member of this unusual group of bacteria was isolated as the sole microorganism. As this microorganism is usually resistant to most antibiotics commonly used to treat peritonitis in patients on CAPD, microbiological investigations with identification and antimicrobial susceptibility tests are mandatory.
Insights
This case report details the first instance of continuous ambulatory peritoneal dialysis (CAPD) peritonitis caused solely by CDC group IVc-2 bacteria. Prompt microbiological investigation is crucial due to the organism
Area of Science:
- Medical Microbiology
- Nephrology
- Infectious Diseases
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a common treatment for end-stage renal disease.
- Peritonitis is a serious complication of CAPD, requiring prompt diagnosis and treatment.
- Certain bacterial groups pose unique challenges in CAPD peritonitis management.
Observation:
- A patient undergoing CAPD developed peritonitis.
- The sole causative microorganism identified was CDC group IVc-2.
- This represents the first reported case of CAPD peritonitis attributed exclusively to this bacterial group.
Findings:
- CDC group IVc-2 bacteria are an unusual cause of CAPD peritonitis.
- This specific microorganism demonstrated resistance to commonly used CAPD peritonitis antibiotics.
- Accurate identification and antimicrobial susceptibility testing are essential for effective treatment.
Implications:
- Highlights the need for expanded microbiological surveillance in CAPD peritonitis.
- Suggests that standard antibiotic protocols may be insufficient for CDC group IVc-2 infections.
- Emphasizes the importance of tailored antimicrobial therapy based on susceptibility data.